Yael L. Maxwell

TCTMD

Marvin ‘Marv' Woodall, Cardiovascular Catalyst, Dies at 88

By: Yael L. Maxwell

With an influential tenure in industry followed by a fruitful post-retirement, Woodall is remembered for his leadership and logic.

TCTMD

Heat and Fire-Related Pollution Compound CV Risk

By: Yael L. Maxwell

The findings should have implications for emergency response and early warning systems, say experts.

TCTMD

David Taggart, Cardiovascular Surgeon and ‘Staunch Truthteller,’ Dies at 69

By: Yael L. Maxwell

Known for his honesty and for igniting controversy, Taggart will be remembered for always putting patient interests first.

TCTMD

David Taggart, Cardiac Surgeon and ‘Staunch Truthteller,' Dies at 69

By: Yael L. Maxwell

Known for his honesty and for igniting controversy, Taggart will be remembered for always putting patient interests first.

TCTMD

CAC Derived From Nongated CT Can Accurately Predict CV Risk

By: Yael L. Maxwell

The findings unlock a trove of data from millions of CT scans done for lung cancer screening or other purposes, researchers say.

TCTMD

Female Sex, Fibrosis Tied to Serious Arrhythmias in Mitral Valve Prolapse

By: Yael L. Maxwell

The findings shine a light on a complication once thought to be benign, especially in women.

TCTMD

ENROUTE Transcarotid Neuroprotection System Recalled Due to Potential for Tip Separation

By: Yael L. Maxwell

Boston Scientific has reported one serious injury, but no deaths, related to the defect. Today the FDA announced a Class I recall.

TCTMD

Aficamten Wins in Nonobstructive Hypertrophic Cardiomyopathy: ACACIA-HCM

By: Yael L. Maxwell

The findings open the door to regulatory approval for this patient group without other treatment options.

TCTMD

Routine Protamine Reduces Minor Bleeding Compared With Selective Use: POPular ACE TAVI

By: Yael L. Maxwell

Without reducing death or major bleeding, Toby Rogers says the results can be interpreted based on one’s ‘starting perspective.’

TCTMD

Beyond CV Events, Evolocumab Lowers All-Cause Mortality: VESALIUS-CV

By: Yael L. Maxwell

It’s unlikely a lipid-lowering agent can directly reduce infection or malignancy, but some argue it could stop a domino effect.